Complete response to docetaxel and carboplatin combination chemotherapy for a stage IV uterine papillary serous carcinoma: a case report.

We report a case of a stage IV uterine papillary serous carcinoma (UPSC) with multiple organ metastases. The patient was treated with docetaxel and carboplatin combination chemotherapy. After five courses, uterine tumor, Douglas tumor, lymphadenopathy, and distant metastases on magnetic resonance imaging or computed tomography scan were completely resoluted. Moreover, endometrial biopsy showed no carcinoma tissues after six courses. We suggest that this regimen may be effective for treatment of advanced-stage UPSC.

[1]  B. Vikram,et al.  Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma. , 2003, International journal of radiation oncology, biology, physics.

[2]  M. Chasen,et al.  Phase II clinical trial of carboplatin and docetaxel in patients with metastatic ovarian cancer: Active combination with low incidence of peripheral neuropathy , 2003, International Journal of Gynecologic Cancer.

[3]  K. Fujita,et al.  Docetaxel in combination with carboplatin for chemo‐naive patients with epithelial ovarian cancer , 2002, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[4]  L. Ramondetta,et al.  Treatment of uterine papillary serous carcinoma with paclitaxel. , 2001, Gynecologic oncology.

[5]  F. Montz,et al.  The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma. , 2001, Gynecologic oncology.

[6]  C. Kainz,et al.  Paclitaxel/carboplatin as first-line chemotherapy in advanced ovarian cancer: efficacy and adverse effects with special consideration of peripheral neurotoxicity. , 2000, Anticancer research.

[7]  M. Markman,et al.  The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma. , 1999, Gynecologic oncology.

[8]  J. Cain,et al.  Uterine papillary serous carcinoma: patterns of metastatic spread. , 1994, Gynecologic oncology.

[9]  P. Schwartz,et al.  Intravenous cisplatin, doxorubicin, and cyclophosphamide in the treatment of uterine papillary serous carcinoma (UPSC). , 1993, Gynecologic oncology.

[10]  J. Wharton,et al.  Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC) , 1991, Gynecologic oncology.